These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32504279)

  • 21. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Aging and Longevity Are Characterized by High Levels of Mitokines.
    Conte M; Ostan R; Fabbri C; Santoro A; Guidarelli G; Vitale G; Mari D; Sevini F; Capri M; Sandri M; Monti D; Franceschi C; Salvioli S
    J Gerontol A Biol Sci Med Sci; 2019 Apr; 74(5):600-607. PubMed ID: 29955888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.
    Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA
    Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
    Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
    Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21.
    Steele HE; Horvath R; Taylor RW
    Neurology; 2016 Nov; 87(22):2286-2287. PubMed ID: 27794110
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes.
    Richter MM; Thomsen MN; Skytte MJ; Kjeldsen SAS; Samkani A; Frystyk J; Magkos F; Holst JJ; Madsbad S; Krarup T; Haugaard SB; Wewer Albrechtsen NJ
    J Endocr Soc; 2024 Feb; 8(4):bvae008. PubMed ID: 38379856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners.
    Campderrós L; Sánchez-Infantes D; Villarroya J; Nescolarde L; Bayès-Genis A; Cereijo R; Roca E; Villarroya F
    Front Physiol; 2020; 11():550102. PubMed ID: 33329017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
    Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
    Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans.
    Richter MM; Plomgaard P
    J Endocr Soc; 2021 Sep; 5(9):bvab121. PubMed ID: 34337280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure.
    Katsumura S; Siddiqui N; Goldsmith MR; Cheah JH; Fujikawa T; Minegishi G; Yamagata A; Yabuki Y; Kobayashi K; Shirouzu M; Inagaki T; Huang TH; Musi N; Topisirovic I; Larsson O; Morita M
    Cell Metab; 2022 Apr; 34(4):564-580.e8. PubMed ID: 35385705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases.
    Trifunov S; Paredes-Fuentes AJ; Badosa C; Codina A; Montoya J; Ruiz-Pesini E; Jou C; Garrabou G; Grau-Junyent JM; Yubero D; Montero R; Muchart J; Ortigoza-Escobar JD; O'Callaghan MM; Nascimento A; Català A; Garcia-Cazorla À; Jimenez-Mallebrera C; Artuch R
    Clin Chem; 2021 Aug; 67(8):1113-1121. PubMed ID: 34352085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
    Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
    Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum growth differentiation factor 15, but not lactate, is elevated in patients with Parkinson's disease.
    Miyaue N; Yabe H; Nagai M
    J Neurol Sci; 2020 Feb; 409():116616. PubMed ID: 31862518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans.
    Yang Y; Wu J; Wang X; Yao J; Lao KS; Qiao Y; Xu Y; Hu Y; Feng Y; Cui Y; Shi S; Zhang J; Liang M; Pan Y; Xie K; Yan K; Li Q; Ye D; Wang Y
    Fertil Steril; 2021 Oct; 116(4):1040-1049. PubMed ID: 34167789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood biomarkers of mitochondrial disease-One for all or all for one?
    Suomalainen A
    Handb Clin Neurol; 2023; 194():251-257. PubMed ID: 36813317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
    Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
    Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.
    Fujita Y; Taniguchi Y; Shinkai S; Tanaka M; Ito M
    Geriatr Gerontol Int; 2016 Mar; 16 Suppl 1():17-29. PubMed ID: 27018280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of diurnal energy balance by mitokines.
    Klaus S; Igual Gil C; Ost M
    Cell Mol Life Sci; 2021 Apr; 78(7):3369-3384. PubMed ID: 33464381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive molecular diagnosis of mitochondrial disorders: qualitative and quantitative approach.
    Wong LJ
    Ann N Y Acad Sci; 2004 Apr; 1011():246-58. PubMed ID: 15126301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.